Literature DB >> 12505781

Simultaneous determination of nine antiretroviral compounds in human plasma using liquid chromatography.

Michele L Turner1, Kedria Reed-Walker, Jennifer R King, Edward P Acosta.   

Abstract

A rapid, sensitive and specific high-performance liquid chromatographic (HPLC) method using UV detection was developed for the determination of nine antiretroviral compounds commonly found in plasma from patients receiving antiretroviral therapy. Analytes include indinavir, saquinavir, ritonavir, amprenavir, lopinavir, delavirdine, efavirenz, nelfinavir and its M8 metabolite. Analytes were isolated from plasma using tert.-butyl methyl ether and separation achieved via reversed-phase liquid chromatography on a C(8) column with a gradient mobile phase. Detection at 210 nm provided adequate sensitivity. Limit of quantification is 50 ng/ml and all analytes demonstrated linearity across 50-10000 ng/ml from a single 200-microliter plasma sample. Recovery from plasma was consistently high (>80%). This novel HPLC methodology allows us to simultaneously determine plasma concentrations of nine antiretrovirals, including lopinavir, in HIV-infected patients on a single HPLC system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12505781     DOI: 10.1016/s1570-0232(02)00822-x

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  8 in total

1.  UPLC-MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues.

Authors:  Jiangeng Huang; Nagsen Gautam; Sai Praneeth R Bathena; Upal Roy; JoEllyn McMillan; Howard E Gendelman; Yazen Alnouti
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-07-01       Impact factor: 3.205

2.  Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults.

Authors:  Leigh Anne Redhage; Ayumi Shintani; David W Haas; Nkiruka Emeagwali; Milica Markovic; Ikwo Oboho; Christopher Mwenya; Husamettin Erdem; Edward P Acosta; Jason D Morrow; Todd Hulgan
Journal:  HIV Clin Trials       Date:  2009 May-Jun

3.  Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline.

Authors:  J Michael Kilby; Ha Youn Lee; J Darren Hazelwood; Anju Bansal; R Patterson Bucy; Michael S Saag; George M Shaw; Edward P Acosta; Victoria A Johnson; Alan S Perelson; Paul A Goepfert
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

4.  Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in human immunodeficiency virus-infected pediatric patients.

Authors:  Jennifer R King; Edward P Acosta; Ram Yogev; Andrew Wiznia; Joyce Kraimer; Bobbie Graham; Vincent Carey; Paula Britto; Patrick Jean-Philippe; John Moye; Douglas Watson
Journal:  Pediatr Infect Dis J       Date:  2009-02       Impact factor: 2.129

5.  Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.

Authors:  David W Haas; Awewura Kwara; Danielle M Richardson; Paxton Baker; Ioannis Papageorgiou; Edward P Acosta; Gene D Morse; Michael H Court
Journal:  J Antimicrob Chemother       Date:  2014-04-11       Impact factor: 5.790

6.  Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.

Authors:  John G Gerber; Douglas W Kitch; Carl J Fichtenbaum; Robert A Zackin; Stéphannie Charles; Evelyn Hogg; Edward P Acosta; Elizabeth Connick; David Wohl; E Milu Kojic; Constance A Benson; Judith A Aberg
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-01       Impact factor: 3.731

7.  Development of an HPLC-UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients.

Authors:  Nitin Charbe; Sara Baldelli; Valeria Cozzi; Simone Castoldi; Dario Cattaneo; Emilio Clementi
Journal:  J Pharm Anal       Date:  2016-06-14

8.  A sensitive and selective liquid chromatography/tandem mass spectrometry method for quantitative analysis of efavirenz in human plasma.

Authors:  Praveen Srivastava; Ganesh S Moorthy; Robert Gross; Jeffrey S Barrett
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.